{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:07:03Z","timestamp":1794002823392,"version":"4.8.0"},"reference-count":193,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7,1]]},"abstract":"<jats:p>Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the potential toxicity of bilirubin, newborn infants must be monitored to identify those who might develop severe hyperbilirubinemia and, in rare cases, acute bilirubin encephalopathy or kernicterus. The focus of this guideline is to reduce the incidence of severe hyperbilirubinemia and bilirubin encephalopathy while minimizing the risks of unintended harm such as maternal anxiety, decreased breastfeeding, and unnecessary costs or treatment. Although kernicterus should almost always be preventable, cases continue to occur. These guidelines provide a framework for the prevention and management of hyperbilirubinemia in newborn infants of 35 or more weeks of gestation. In every infant, we recommend that clinicians 1) promote and support successful breastfeeding; 2) perform a systematic assessment before discharge for the risk of severe hyperbilirubinemia; 3) provide early and focused follow-up based on the risk assessment; and 4) when indicated, treat newborns with phototherapy or exchange transfusion to prevent the development of severe hyperbilirubinemia and, possibly, bilirubin encephalopathy (kernicterus).<\/jats:p>","DOI":"10.1542\/peds.114.1.297","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"297-316","source":"Crossref","is-referenced-by-count":2200,"title":["Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation"],"prefix":"10.1542","volume":"114","author":[{"name":"Subcommittee on Hyperbilirubinemia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"2021121006502503900_R1","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics.\u20081994;94:558\u2013562","DOI":"10.1542\/peds.94.4.558"},{"key":"2021121006502503900_R2","unstructured":"Ip S, Glicken S, Kulig J, Obrien R, Sege R, Lau J. Management of Neonatal Hyperbilirubinemia. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2003. AHRQ Publication 03-E011"},{"key":"2021121006502503900_R3","unstructured":"Ip S, Chung M, Kulig J. et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics.\u20082004;113(6). Available at: www.pediatrics.org\/cgi\/content\/full\/113\/6\/e644"},{"key":"2021121006502503900_R4","unstructured":"American Academy of Pediatrics, Steering Committee on Quality Improvement and Management. A taxonomy of recommendations. Pediatrics.\u20082004; In press"},{"key":"2021121006502503900_R5","doi-asserted-by":"crossref","unstructured":"Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr.\u20082002;140:396\u2013403","DOI":"10.1067\/mpd.2002.123098"},{"key":"2021121006502503900_R6","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics.\u20081995;96:730\u2013733","DOI":"10.1542\/peds.96.4.730"},{"key":"2021121006502503900_R7","doi-asserted-by":"crossref","unstructured":"MacDonald M. Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics.\u20081995;96:734\u2013738","DOI":"10.1542\/peds.96.4.734"},{"key":"2021121006502503900_R8","doi-asserted-by":"crossref","unstructured":"Penn AA, Enzman DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics.\u20081994;93:1003\u20131006","DOI":"10.1542\/peds.93.6.1003"},{"key":"2021121006502503900_R9","doi-asserted-by":"crossref","unstructured":"Washington EC, Ector W, Abboud M, Ohning B, Holden K. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J.\u20081995;88:776\u2013779","DOI":"10.1097\/00007611-199507000-00019"},{"key":"2021121006502503900_R10","doi-asserted-by":"crossref","unstructured":"Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr.\u20082000;89:1213\u20131217","DOI":"10.1111\/j.1651-2227.2000.tb00738.x"},{"key":"2021121006502503900_R11","unstructured":"Institue of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC: National Academy Press; 2001"},{"key":"2021121006502503900_R12","unstructured":"American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 5th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2002:220\u2013224"},{"key":"2021121006502503900_R13","doi-asserted-by":"crossref","unstructured":"Bertini G, Dani C, Trochin M, Rubaltelli F. Is breastfeeding really favoring early neonatal jaundice?Pediatrics.\u20082001;107(3). Available at: www.pediatrics.org\/cgi\/content\/full\/107\/3\/e41","DOI":"10.1542\/peds.107.3.e41"},{"key":"2021121006502503900_R14","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Gifford K. Normal serum bilirubin levels in the newborn and the effect of breast-feeding. Pediatrics.\u20081986;78:837\u2013843","DOI":"10.1542\/peds.78.5.837"},{"key":"2021121006502503900_R15","doi-asserted-by":"crossref","unstructured":"Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full-term neonates. Pediatrics.\u20081990;86:171\u2013175","DOI":"10.1542\/peds.86.2.171"},{"key":"2021121006502503900_R16","doi-asserted-by":"crossref","unstructured":"De Carvalho M, Klaus MH, Merkatz RB. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child.\u20081982;136:737\u2013738","DOI":"10.1001\/archpedi.1982.03970440081024"},{"key":"2021121006502503900_R17","doi-asserted-by":"crossref","unstructured":"Varimo P, Simila\u0308 S, Wendt L, Kolvisto M. Frequency of breast feeding and hyperbilirubinemia [letter]. Clin Pediatr (Phila).\u20081986;25:112","DOI":"10.1177\/000992288602500212"},{"key":"2021121006502503900_R18","doi-asserted-by":"crossref","unstructured":"De Carvalho M, Holl M, Harvey D. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch Dis Child.\u20081981;56:568\u2013569","DOI":"10.1136\/adc.56.7.568"},{"key":"2021121006502503900_R19","doi-asserted-by":"crossref","unstructured":"Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand.\u20081982;71:759\u2013761","DOI":"10.1111\/j.1651-2227.1982.tb09515.x"},{"key":"2021121006502503900_R20","unstructured":"Madlon-Kay DJ. Identifying ABO incompatibility in newborns: selective vs automatic testing. J Fam Pract.\u20081992;35:278\u2013280"},{"key":"2021121006502503900_R21","doi-asserted-by":"crossref","unstructured":"Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child.\u20081969;118:454\u2013458","DOI":"10.1001\/archpedi.1969.02100040456007"},{"key":"2021121006502503900_R22","doi-asserted-by":"crossref","unstructured":"Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med.\u20082000;154:391\u2013394","DOI":"10.1001\/archpedi.154.4.391"},{"key":"2021121006502503900_R23","doi-asserted-by":"crossref","unstructured":"Davidson LT, Merritt KK, Weech AA. Hyperbilirubinemia in the newborn. Am J Dis Child.\u20081941;61:958\u2013980","DOI":"10.1001\/archpedi.1941.02000110046005"},{"key":"2021121006502503900_R24","doi-asserted-by":"crossref","unstructured":"Tayaba R, Gribetz D, Gribetz I, Holzman IR. Noninvasive estimation of serum bilirubin. Pediatrics.\u20081998;102(3). Available at: www.pediatrics.org\/cgi\/content\/full\/102\/3\/e28","DOI":"10.1542\/peds.102.3.e28"},{"key":"2021121006502503900_R25","doi-asserted-by":"crossref","unstructured":"Bhutani V, Gourley GR, Adler S, Kreamer B, Dalman C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics.\u20082000;106(2). Available at: www.pediatrics.org\/cgi\/content\/full\/106\/2\/e17","DOI":"10.1542\/peds.106.2.e17"},{"key":"2021121006502503900_R26","doi-asserted-by":"crossref","unstructured":"Yasuda S, Itoh S, Isobe K, et al. New transcutaneous jaundice device with two optical paths. J Perinat Med.\u20082003;31:81\u201388","DOI":"10.1515\/JPM.2003.012"},{"key":"2021121006502503900_R27","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Ostrea EJ Jr, Touch S, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics.\u20082004;113:1638\u20131645","DOI":"10.1542\/peds.113.6.1628"},{"key":"2021121006502503900_R28","doi-asserted-by":"crossref","unstructured":"Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, bilicheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr.\u20082002;91:203\u2013211","DOI":"10.1111\/j.1651-2227.2002.tb01696.x"},{"key":"2021121006502503900_R29","doi-asserted-by":"crossref","unstructured":"Rubaltelli FF, Gourley GR, Loskamp N, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics.\u20082001;107:1264\u20131271","DOI":"10.1542\/peds.107.6.1264"},{"key":"2021121006502503900_R30","doi-asserted-by":"crossref","unstructured":"Newman TB, Liljestrand P, Escobar GJ. Jaundice noted in the first 24 hours after birth in a managed care organization. Arch Pediatr Adolesc Med.\u20082002;156:1244\u20131250","DOI":"10.1001\/archpedi.156.12.1244"},{"key":"2021121006502503900_R31","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics.\u20081999;103:6\u201314","DOI":"10.1542\/peds.103.1.6"},{"key":"2021121006502503900_R32","doi-asserted-by":"crossref","unstructured":"Garcia FJ, Nager AL. Jaundice as an early diagnostic sign of urinary tract infection in infancy. Pediatrics.\u20082002;109:846\u2013851","DOI":"10.1542\/peds.109.5.846"},{"key":"2021121006502503900_R33","doi-asserted-by":"crossref","unstructured":"Kaplan M, Hammerman C. Severe neonatal hyperbilirubinemia: a potential complication of glucose-6-phosphate dehydrogenase deficiency. Clin Perinatol.\u20081998;25:575\u2013590","DOI":"10.1016\/S0095-5108(18)30098-8"},{"key":"2021121006502503900_R34","doi-asserted-by":"crossref","unstructured":"Valaes T. Severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency: pathogenesis and global epidemiology. Acta Paediatr Suppl.\u20081994;394:58\u201376","DOI":"10.1111\/j.1651-2227.1994.tb13216.x"},{"key":"2021121006502503900_R35","doi-asserted-by":"crossref","unstructured":"Alpay F, Sarici S, Tosuncuk HD, Serdar MA, Inanc\u0327 N, Go\u0308kc\u0327ay E. The value of first-day bilirubin measurement in predicting the development of significant hyperbilirubinemia in healthy term newborns. Pediatrics.\u20082000;106(2). Available at: www.pediatrics.org\/cgi\/content\/full\/106\/2\/e16","DOI":"10.1542\/peds.106.2.e16"},{"key":"2021121006502503900_R36","doi-asserted-by":"crossref","unstructured":"Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr.\u20082001;90:166\u2013170","DOI":"10.1111\/j.1651-2227.2001.tb00279.x"},{"key":"2021121006502503900_R37","doi-asserted-by":"crossref","unstructured":"Kaplan M, Hammerman C, Feldman R, Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics.\u20082000;105:533\u2013537","DOI":"10.1542\/peds.105.3.533"},{"key":"2021121006502503900_R38","doi-asserted-by":"crossref","unstructured":"Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics.\u20082001;108:31\u201339","DOI":"10.1542\/peds.108.1.31"},{"key":"2021121006502503900_R39","doi-asserted-by":"crossref","unstructured":"Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med.\u20082000;154:1140\u20131147","DOI":"10.1001\/archpedi.154.11.1140"},{"key":"2021121006502503900_R40","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Kring EA. Length of stay, jaundice, and hospital readmission. Pediatrics.\u20081998;101:995\u2013998","DOI":"10.1542\/peds.101.6.995"},{"key":"2021121006502503900_R41","doi-asserted-by":"crossref","unstructured":"Gale R, Seidman DS, Dollberg S, Stevenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr.\u20081990;10:82\u201386","DOI":"10.1097\/00005176-199001000-00016"},{"key":"2021121006502503900_R42","doi-asserted-by":"crossref","unstructured":"Berk MA, Mimouni F, Miodovnik M, Hertzberg V, Valuck J. Macrosomia in infants of insulin-dependent diabetic mothers. Pediatrics.\u20081989;83:1029\u20131034","DOI":"10.1542\/peds.83.6.1029"},{"key":"2021121006502503900_R43","doi-asserted-by":"crossref","unstructured":"Peevy KJ, Landaw SA, Gross SJ. Hyperbilirubinemia in infants of diabetic mothers. Pediatrics.\u20081980;66:417\u2013419","DOI":"10.1542\/peds.66.3.417"},{"key":"2021121006502503900_R44","doi-asserted-by":"crossref","unstructured":"Soskolne El, Schumacher R, Fyock C, Young ML, Schork A. The effect of early discharge and other factors on readmission rates of newborns. Arch Pediatr Adolesc Med.\u20081996;150:373\u2013379","DOI":"10.1001\/archpedi.1996.02170290039006"},{"key":"2021121006502503900_R45","doi-asserted-by":"crossref","unstructured":"Ebbesen F, Brodersen R. Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood\/brain bilirubin transfer equilibrium. Early Hum Dev.\u20081982;6:341\u2013355","DOI":"10.1016\/0378-3782(82)90072-X"},{"key":"2021121006502503900_R46","doi-asserted-by":"crossref","unstructured":"Cashore WJ, Oh W, Brodersen R. Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand.\u20081983;72:415\u2013419","DOI":"10.1111\/j.1651-2227.1983.tb09739.x"},{"key":"2021121006502503900_R47","doi-asserted-by":"crossref","unstructured":"Cashore WJ. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr.\u20081980;96:521\u2013527","DOI":"10.1016\/S0022-3476(80)80860-2"},{"key":"2021121006502503900_R48","doi-asserted-by":"crossref","unstructured":"Bratlid D. How bilirubin gets into the brain. Clin Perinatol.\u20081990;17:449\u2013465","DOI":"10.1016\/S0095-5108(18)30578-5"},{"key":"2021121006502503900_R49","unstructured":"Wennberg RP. Cellular basis of bilirubin toxicity. N Y State J Med.\u20081991;91:493\u2013496"},{"key":"2021121006502503900_R50","doi-asserted-by":"crossref","unstructured":"Eggert P, Stick C, Schroder H. On the distribution of irradiation intensity in phototherapy. Measurements of effective irradiance in an incubator. Eur J Pediatr.\u20081984;142:58\u201361","DOI":"10.1007\/BF00442593"},{"key":"2021121006502503900_R51","doi-asserted-by":"crossref","unstructured":"Maisels MJ. Why use homeopathic doses of phototherapy?Pediatrics.\u20081996;98:283\u2013287","DOI":"10.1542\/peds.98.2.283"},{"key":"2021121006502503900_R52","doi-asserted-by":"crossref","unstructured":"Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics.\u20081994;93:488\u2013494","DOI":"10.1542\/peds.93.3.488"},{"key":"2021121006502503900_R53","unstructured":"American Association of Blood Banks Technical Manual Committee. Perinatal issues in transfusion practice. In: Brecher M, ed. Technical Manual. Bethesda, MD: American Association of Blood Banks; 2002:497\u2013515"},{"key":"2021121006502503900_R54","doi-asserted-by":"crossref","unstructured":"Garland JS, Alex C, Deacon JS, Raab K. Treatment of infants with indirect hyperbilirubinemia. Readmission to birth hospital vs nonbirth hospital. Arch Pediatr Adolesc Med.\u20081994;148:1317\u20131321","DOI":"10.1001\/archpedi.1994.02170120079015"},{"key":"2021121006502503900_R55","doi-asserted-by":"crossref","unstructured":"Gottstein R, Cooke R. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed.\u20082003;88:F6\u2013F10","DOI":"10.1136\/fn.88.1.F6"},{"key":"2021121006502503900_R56","doi-asserted-by":"crossref","unstructured":"Sato K, Hara T, Kondo T, Iwao H, Honda S, Ueda K. High-dose intravenous gammaglobulin therapy for neonatal immune haemolytic jaundice due to blood group incompatibility. Acta Paediatr Scand.\u20081991;80:163\u2013166","DOI":"10.1111\/j.1651-2227.1991.tb11828.x"},{"key":"2021121006502503900_R57","doi-asserted-by":"crossref","unstructured":"Rubo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr.\u20081992;121:93\u201397","DOI":"10.1016\/S0022-3476(05)82551-X"},{"key":"2021121006502503900_R58","doi-asserted-by":"crossref","unstructured":"Hammerman C, Kaplan M, Vreman HJ, Stevenson DK. Intravenous immune globulin in neonatal ABO isoimmunization: factors associated with clinical efficacy. Biol Neonate.\u20081996;70:69\u201374","DOI":"10.1159\/000244350"},{"key":"2021121006502503900_R59","unstructured":"Johnson L, Boggs TR. Bilirubin-dependent brain damage: incidence and indications for treatment. In: Odell GB, Schaffer R, Simopoulos AP, eds. Phototherapy in the Newborn: An Overview. Washington, DC: National Academy of Sciences; 1974:122\u2013149"},{"key":"2021121006502503900_R60","doi-asserted-by":"crossref","unstructured":"Ozmert E, Erdem G, Topcu M. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr.\u20081996;85:1440\u20131444","DOI":"10.1111\/j.1651-2227.1996.tb13949.x"},{"key":"2021121006502503900_R61","unstructured":"Volpe JJ. Neurology of the Newborn. 4th ed. Philadelphia, PA: W. B. Saunders; 2001"},{"key":"2021121006502503900_R62","doi-asserted-by":"crossref","unstructured":"Harris M, Bernbaum J, Polin J, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics.\u20082001;107:1075\u20131080","DOI":"10.1542\/peds.107.5.1075"},{"key":"2021121006502503900_R63","unstructured":"Osborn LM, Bolus R. Breast feeding and jaundice in the first week of life. J Fam Pract.\u20081985;20:475\u2013480"},{"key":"2021121006502503900_R64","doi-asserted-by":"crossref","unstructured":"Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions. Pediatrics.\u20081993;91:470\u2013473","DOI":"10.1542\/peds.91.2.470"},{"key":"2021121006502503900_R65","unstructured":"Amato M, Howald H, von Muralt G. Interruption of breast-feeding versus phototherapy as treatment of hyperbilirubinemia in full-term infants. Helv Paediatr Acta.\u20081985;40:127\u2013131"},{"key":"2021121006502503900_R66","unstructured":"Maisels MJ, Gifford K, Antle CE, Leib GR. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics.\u20081988;81:505\u2013511"},{"key":"2021121006502503900_R67","doi-asserted-by":"crossref","unstructured":"Newman TB, Easterling MJ. Yield of reticulocyte counts and blood smears in term infants. Clin Pediatr (Phila).\u20081994;33:71\u201376","DOI":"10.1177\/000992289403300202"},{"key":"2021121006502503900_R68","doi-asserted-by":"crossref","unstructured":"Herschel M, Karrison T, Wen M, Caldarelli L, Baron B. Evaluation of the direct antiglobulin (Coombs\u2019) test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs\u2019 test with ETCOc for detecting significant jaundice. J Perinatol.\u20082002;22:341\u2013347","DOI":"10.1038\/sj.jp.7210702"},{"key":"2021121006502503900_R69","doi-asserted-by":"crossref","unstructured":"Stevenson DK, Vreman HJ. Carbon monoxide and bilirubin production in neonates. Pediatrics.\u20081997;100:252\u2013254","DOI":"10.1542\/peds.100.2.252"},{"key":"2021121006502503900_R70","doi-asserted-by":"crossref","unstructured":"Vreman HJ, Verter J, Oh W, et al. Interlaboratory variability of bilirubin measurements. Clin Chem.\u20081996;42:869\u2013873","DOI":"10.1093\/clinchem\/42.6.869"},{"key":"2021121006502503900_R71","doi-asserted-by":"crossref","unstructured":"Lo S, Doumas BT, Ashwood E. Performance of bilirubin determinations in US laboratories\u2014revisited. Clin Chem.\u20082004;50:190\u2013194","DOI":"10.1373\/clinchem.2003.019216"},{"key":"2021121006502503900_R72","doi-asserted-by":"crossref","unstructured":"Kappas A, Drummond GS, Henschke C, Valaes T. Direct comparison of Sn-mesoporphyrin, an inhibitor of bilirubin production, and phototherapy in controlling hyperbilirubinemia in term and near-term newborns. Pediatrics.\u20081995;95:468\u2013474","DOI":"10.1542\/peds.95.4.468"},{"key":"2021121006502503900_R73","doi-asserted-by":"crossref","unstructured":"Martinez JC, Garcia HO, Otheguy L, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics.\u20081999;103:1\u20135","DOI":"10.1542\/peds.103.1.1"},{"key":"2021121006502503900_R74","doi-asserted-by":"crossref","unstructured":"Suresh G, Martin CL, Soll R. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates. Cochrane Database Syst Rev.\u20082003;2:CD004207","DOI":"10.1002\/14651858.CD004207"},{"key":"2021121006502503900_R75","doi-asserted-by":"crossref","unstructured":"Kappas A, Drummond GS, Munson DP, Marshall JR. Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah\u2019s Witness newborns as an alternative to exchange transfusion. Pediatrics.\u20082001;108:1374\u20131377","DOI":"10.1542\/peds.108.6.1374"},{"key":"2021121006502503900_R76","unstructured":"American Academy of Pediatrics, Steering Committee on Quality Improvement and Management. Classification of recommendations for clinical practice guidelines. Pediatrics.\u20082004; In press"},{"key":"2021121006502503900_R77","doi-asserted-by":"crossref","unstructured":"Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr.\u20082002;140:396\u2013403","DOI":"10.1067\/mpd.2002.123098"},{"key":"2021121006502503900_R78","unstructured":"Volpe JJ. Neurology of the Newborn. 4th ed. Philadelphia, PA: W. B. Saunders; 2001"},{"key":"2021121006502503900_R79","doi-asserted-by":"crossref","unstructured":"Harris M, Bernbaum J, Polin J, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics.\u20082001;107:1075\u20131080","DOI":"10.1542\/peds.107.5.1075"},{"key":"2021121006502503900_R80","doi-asserted-by":"crossref","unstructured":"Van Praagh R. Diagnosis of kernicterus in the neonatal period. Pediatrics.\u20081961;28:870\u2013876","DOI":"10.1542\/peds.28.6.870"},{"key":"2021121006502503900_R81","doi-asserted-by":"crossref","unstructured":"Jones MH, Sands R, Hyman CB, Sturgeon P, Koch FP. Longitudinal study of incidence of central nervous system damage following erythroblastosis fetalis. Pediatrics.\u20081954;14:346\u2013350","DOI":"10.1542\/peds.14.4.346"},{"key":"2021121006502503900_R82","doi-asserted-by":"crossref","unstructured":"Kramer LI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child.\u20081969;118:454\u2013458","DOI":"10.1001\/archpedi.1969.02100040456007"},{"key":"2021121006502503900_R83","doi-asserted-by":"crossref","unstructured":"Moyer VA, Ahn C, Sneed S. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med.\u20082000;154:391\u2013394","DOI":"10.1001\/archpedi.154.4.391"},{"key":"2021121006502503900_R84","doi-asserted-by":"crossref","unstructured":"Davidson LT, Merritt KK, Weech AA. Hyperbilirubinemia in the newborn. Am J Dis Child.\u20081941;61:958\u2013980","DOI":"10.1001\/archpedi.1941.02000110046005"},{"key":"2021121006502503900_R85","doi-asserted-by":"crossref","unstructured":"Tayaba R, Gribetz D, Gribetz I, Holzman IR. Noninvasive estimation of serum bilirubin. Pediatrics.\u20081998;102(3). Available at: www.pediatrics.org\/cgi\/content\/full\/102\/3\/e28","DOI":"10.1542\/peds.102.3.e28"},{"key":"2021121006502503900_R86","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Kring E. Transcutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Pediatrics.\u20081997;99:599\u2013601","DOI":"10.1542\/peds.99.4.599"},{"key":"2021121006502503900_R87","unstructured":"Ip S, Glicken S, Kulig J, Obrien R, Sege R, Lau J. Management of Neonatal Hyperbilirubinemia. Rockville, MD: US Department of Health and Human Services, Agency for Healthcare Research and Quality; 2003. AHRQ Publication 03-E011"},{"key":"2021121006502503900_R88","doi-asserted-by":"crossref","unstructured":"Bhutani V, Gourley GR, Adler S, Kreamer B, Dalman C, Johnson LH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics.\u20082000;106(2). Available at: www.pediatrics.org\/cgi\/content\/full\/106\/2\/e17","DOI":"10.1542\/peds.106.2.e17"},{"key":"2021121006502503900_R89","doi-asserted-by":"crossref","unstructured":"Yasuda S, Itoh S, Isobe K, et al. New transcutaneous jaundice device with two optical paths. J Perinat Med.\u20082003;31:81\u201388","DOI":"10.1515\/JPM.2003.012"},{"key":"2021121006502503900_R90","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Ostrea EJ Jr, Touch S, et al. Evaluation of a new transcutaneous bilirubinometer. Pediatrics.\u20082004;113:1638\u20131645","DOI":"10.1542\/peds.113.6.1628"},{"key":"2021121006502503900_R91","doi-asserted-by":"crossref","unstructured":"Ebbesen F, Rasmussen LM, Wimberley PD. A new transcutaneous bilirubinometer, bilicheck, used in the neonatal intensive care unit and the maternity ward. Acta Paediatr.\u20082002;91:203\u2013211","DOI":"10.1111\/j.1651-2227.2002.tb01696.x"},{"key":"2021121006502503900_R92","doi-asserted-by":"crossref","unstructured":"Rubaltelli FF, Gourley GR, Loskamp N, et al. Transcutaneous bilirubin measurement: a multicenter evaluation of a new device. Pediatrics.\u20082001;107:1264\u20131271","DOI":"10.1542\/peds.107.6.1264"},{"key":"2021121006502503900_R93","doi-asserted-by":"crossref","unstructured":"Engle WD, Jackson GL, Sendelbach D, Manning D, Frawley W. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics.\u20082002;110:61\u201367","DOI":"10.1542\/peds.110.1.61"},{"key":"2021121006502503900_R94","doi-asserted-by":"crossref","unstructured":"Schumacher R. Transcutaneous bilirubinometry and diagnostic tests: \u201cthe right job for the tool.\u201d Pediatrics.\u20082002;110:407\u2013408","DOI":"10.1542\/peds.110.2.407"},{"key":"2021121006502503900_R95","doi-asserted-by":"crossref","unstructured":"Vreman HJ, Verter J, Oh W, et al. Interlaboratory variability of bilirubin measurements. Clin Chem.\u20081996;42:869\u2013873","DOI":"10.1093\/clinchem\/42.6.869"},{"key":"2021121006502503900_R96","doi-asserted-by":"crossref","unstructured":"Doumas BT, Eckfeldt JH. Errors in measurement of total bilirubin: a perennial problem. Clin Chem.\u20081996;42:845\u2013848","DOI":"10.1093\/clinchem\/42.6.845"},{"key":"2021121006502503900_R97","doi-asserted-by":"crossref","unstructured":"Lo S, Doumas BT, Ashwood E. Performance of bilirubin determinations in US laboratories\u2014revisited. Clin Chem.\u20082004;50:190\u2013194","DOI":"10.1373\/clinchem.2003.019216"},{"key":"2021121006502503900_R98","unstructured":"Ip S, Chung M, Kulig J. et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics.\u20082004;113(6). Available at: www.pediatrics.org\/cgi\/content\/full\/113\/6\/e644"},{"key":"2021121006502503900_R99","doi-asserted-by":"crossref","unstructured":"Leslie GI, Philips JB, Cassady G. Capillary and venous bilirubin values: are they really different?Am J Dis Child.\u20081987;141:1199\u20131200","DOI":"10.1001\/archpedi.1987.04460110069024"},{"key":"2021121006502503900_R100","doi-asserted-by":"crossref","unstructured":"Eidelman AI, Schimmel MS, Algur N, Eylath U. Capillary and venous bilirubin values: they are different\u2014and how [letter]!Am J Dis Child.\u20081989;143:642","DOI":"10.1001\/archpedi.1989.02150180020007"},{"key":"2021121006502503900_R101","doi-asserted-by":"crossref","unstructured":"Watkinson LR, St John A, Penberthy LA. Investigation into paediatric bilirubin analyses in Australia and New Zealand. J Clin Pathol.\u20081982;35:52\u201358","DOI":"10.1136\/jcp.35.1.52"},{"key":"2021121006502503900_R102","doi-asserted-by":"crossref","unstructured":"Bertini G, Dani C, Trochin M, Rubaltelli F. Is breastfeeding really favoring early neonatal jaundice?Pediatrics.\u20082001;107(3). Available at: www.pediatrics.org\/cgi\/content\/full\/107\/3\/e41","DOI":"10.1542\/peds.107.3.e41"},{"key":"2021121006502503900_R103","doi-asserted-by":"crossref","unstructured":"De Carvalho M, Klaus MH, Merkatz RB. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child.\u20081982;136:737\u2013738","DOI":"10.1001\/archpedi.1982.03970440081024"},{"key":"2021121006502503900_R104","doi-asserted-by":"crossref","unstructured":"De Carvalho M, Holl M, Harvey D. Effects of water supplementation on physiological jaundice in breast-fed babies. Arch Dis Child.\u20081981;56:568\u2013569","DOI":"10.1136\/adc.56.7.568"},{"key":"2021121006502503900_R105","doi-asserted-by":"crossref","unstructured":"Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand.\u20081982;71:759\u2013761","DOI":"10.1111\/j.1651-2227.1982.tb09515.x"},{"key":"2021121006502503900_R106","doi-asserted-by":"crossref","unstructured":"Butler DA, MacMillan JP. Relationship of breast feeding and weight loss to jaundice in the newborn period: review of the literature and results of a study. Cleve Clin Q.\u20081983;50:263\u2013268","DOI":"10.3949\/ccjm.50.3.263"},{"key":"2021121006502503900_R107","doi-asserted-by":"crossref","unstructured":"De Carvalho M, Robertson S, Klaus M. Fecal bilirubin excretion and serum bilirubin concentration in breast-fed and bottle-fed infants. J Pediatr.\u20081985;107:786\u2013790","DOI":"10.1016\/S0022-3476(85)80418-2"},{"key":"2021121006502503900_R108","doi-asserted-by":"crossref","unstructured":"Gourley GR, Kreamer B, Arend R. The effect of diet on feces and jaundice during the first three weeks of life. Gastroenterology.\u20081992;103:660\u2013667","DOI":"10.1016\/0016-5085(92)90862-S"},{"key":"2021121006502503900_R109","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Gifford K. Breast-feeding, weight loss, and jaundice. J Pediatr.\u20081983;102:117\u2013118","DOI":"10.1016\/S0022-3476(83)80305-9"},{"key":"2021121006502503900_R110","doi-asserted-by":"crossref","unstructured":"Laing IA, Wong CM. Hypernatraemia in the first few days: is the incidence rising?Arch Dis Child Fetal Neonatal Ed.\u20082002;87:F158\u2013F162","DOI":"10.1136\/fn.87.3.F158"},{"key":"2021121006502503900_R111","unstructured":"Lawrence RA. Management of the mother-infant nursing couple. In: A Breastfeeding Guide for the Medical Profession. 4th ed. St Louis, MO: Mosby-Year Book, Inc; 1994:215-277"},{"key":"2021121006502503900_R112","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Newman TB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics.\u20081999;103:493\u2013495","DOI":"10.1542\/peds.103.2.493"},{"key":"2021121006502503900_R113","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics.\u20081999;103:6\u201314","DOI":"10.1542\/peds.103.1.6"},{"key":"2021121006502503900_R114","doi-asserted-by":"crossref","unstructured":"Beutler E. Glucose-6-phosphate dehydrogenase deficiency. Blood.\u20081994;84:3613\u20133636","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613"},{"key":"2021121006502503900_R115","doi-asserted-by":"crossref","unstructured":"Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefield PG, Ryan KJ. Epidemiology of neonatal hyperbilirubinemia. Pediatrics.\u20081985;75:770\u2013774","DOI":"10.1542\/peds.75.4.770"},{"key":"2021121006502503900_R116","doi-asserted-by":"crossref","unstructured":"Newman TB, Easterling MJ, Goldman ES, Stevenson DK. Laboratory evaluation of jaundiced newborns: frequency, cost and yield. Am J Dis Child.\u20081990;144:364\u2013368","DOI":"10.1001\/archpedi.1990.02150270114039"},{"key":"2021121006502503900_R117","doi-asserted-by":"crossref","unstructured":"Martinez JC, Maisels MJ, Otheguy L, et al. Hyperbilirubinemia in the breast-fed newborn: a controlled trial of four interventions. Pediatrics.\u20081993;91:470\u2013473","DOI":"10.1542\/peds.91.2.470"},{"key":"2021121006502503900_R118","doi-asserted-by":"crossref","unstructured":"Maisels MJ. Phototherapy\u2014traditional and nontraditional. J Perinatol.\u20082001;21(suppl 1):S93\u2013S97","DOI":"10.1038\/sj.jp.7210642"},{"key":"2021121006502503900_R119","doi-asserted-by":"crossref","unstructured":"Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics.\u20081985;75:393\u2013400","DOI":"10.1542\/peds.75.2.393"},{"key":"2021121006502503900_R120","doi-asserted-by":"crossref","unstructured":"Armitage P, Mollison PL. Further analysis of controlled trials of treatment of hemolytic disease of the newborn. J Obstet Gynaecol Br Emp.\u20081953;60:602\u2013605","DOI":"10.1111\/j.1471-0528.1953.tb07250.x"},{"key":"2021121006502503900_R121","doi-asserted-by":"crossref","unstructured":"Mollison PL, Walker W. Controlled trials of the treatment of haemolytic disease of the newborn. Lancet.\u20081952;1:429\u2013433","DOI":"10.1016\/S0140-6736(52)91949-1"},{"key":"2021121006502503900_R122","doi-asserted-by":"crossref","unstructured":"Hsia DYY, Allen FH, Gellis SS, Diamond LK. Erythroblastosis fetalis. VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med.\u20081952;247:668\u2013671","DOI":"10.1056\/NEJM195210302471802"},{"key":"2021121006502503900_R123","doi-asserted-by":"crossref","unstructured":"Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of healthy full-term infants?Clin Perinatol.\u20081990;17:331\u2013358","DOI":"10.1016\/S0095-5108(18)30571-2"},{"key":"2021121006502503900_R124","doi-asserted-by":"crossref","unstructured":"Ozmert E, Erdem G, Topcu M. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr.\u20081996;85:1440\u20131444","DOI":"10.1111\/j.1651-2227.1996.tb13949.x"},{"key":"2021121006502503900_R125","doi-asserted-by":"crossref","unstructured":"Perlman JM, Rogers B, Burns D. Kernicterus findings at autopsy in 2 sick near-term infants. Pediatrics.\u20081997;99:612\u2013615","DOI":"10.1542\/peds.99.4.612"},{"key":"2021121006502503900_R126","doi-asserted-by":"crossref","unstructured":"Gartner LM, Snyder RN, Chabon RS, Bernstein J. Kernicterus: high incidence in premature infants with low serum bilirubin concentration. Pediatrics.\u20081970;45:906\u2013917","DOI":"10.1542\/peds.45.6.906"},{"key":"2021121006502503900_R127","doi-asserted-by":"crossref","unstructured":"Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present, and future. Pediatrics.\u20081992;90:707\u2013715","DOI":"10.1542\/peds.90.5.707"},{"key":"2021121006502503900_R128","doi-asserted-by":"crossref","unstructured":"Watchko J, Claassen D. Kernicterus in premature infants: current prevalence and relationship to NICHD Phototherapy Study exchange criteria. Pediatrics.\u20081994;93(6 Pt 1):996\u2013999","DOI":"10.1542\/peds.93.6.996"},{"key":"2021121006502503900_R129","doi-asserted-by":"crossref","unstructured":"Stern L, Denton RL. Kernicterus in small, premature infants. Pediatrics.\u20081965;35:486\u2013485","DOI":"10.1542\/peds.35.3.483"},{"key":"2021121006502503900_R130","doi-asserted-by":"crossref","unstructured":"Turkel SB, Guttenberg ME, Moynes DR, Hodgman JE. Lack of identifiable risk factors for kernicterus. Pediatrics.\u20081980;66:502\u2013506","DOI":"10.1542\/peds.66.4.502"},{"key":"2021121006502503900_R131","doi-asserted-by":"crossref","unstructured":"Kim MH, Yoon JJ, Sher J, Brown AK. Lack of predictive indices in kernicterus. A comparison of clinical and pathologic factors in infants with or without kernicterus. Pediatrics.\u20081980;66:852\u2013858","DOI":"10.1542\/peds.66.6.852"},{"key":"2021121006502503900_R132","doi-asserted-by":"crossref","unstructured":"Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med.\u20082000;154:1140\u20131147","DOI":"10.1001\/archpedi.154.11.1140"},{"key":"2021121006502503900_R133","doi-asserted-by":"crossref","unstructured":"Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics.\u20081999;104:1198\u20131203","DOI":"10.1542\/peds.104.S6.1198"},{"key":"2021121006502503900_R134","doi-asserted-by":"crossref","unstructured":"Vohr BR. New approaches to assessing the risks of hyperbilirubinemia. Clin Perinatol.\u20081990;17:293\u2013306","DOI":"10.1016\/S0095-5108(18)30569-4"},{"key":"2021121006502503900_R135","doi-asserted-by":"crossref","unstructured":"Perlman M, Fainmesser P, Sohmer H, Tamari H, Wax Y, Pevsmer B. Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics.\u20081983;72:658\u2013664","DOI":"10.1542\/peds.72.5.658"},{"key":"2021121006502503900_R136","doi-asserted-by":"crossref","unstructured":"Nakamura H, Takada S, Shimabuku R, Matsuo M, Matsuo T, Negishi H. Auditory and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics.\u20081985;75:703\u2013708","DOI":"10.1542\/peds.75.4.703"},{"key":"2021121006502503900_R137","doi-asserted-by":"crossref","unstructured":"Nwaesei CG, Van Aerde J, Boyden M, Perlman M. Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion. Pediatrics.\u20081984;74:800\u2013803","DOI":"10.1542\/peds.74.5.800"},{"key":"2021121006502503900_R138","doi-asserted-by":"crossref","unstructured":"Wennberg RP, Ahlfors CE, Bickers R, McMurtry CA, Shetter JL. Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: improvement with exchange transfusion. J Pediatr.\u20081982;100:624\u2013626","DOI":"10.1016\/S0022-3476(82)80771-3"},{"key":"2021121006502503900_R139","doi-asserted-by":"crossref","unstructured":"Soorani-Lunsing I, Woltil H, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?Pediatr Res.\u20082001;50:701\u2013705","DOI":"10.1203\/00006450-200112000-00012"},{"key":"2021121006502503900_R140","doi-asserted-by":"crossref","unstructured":"Grimmer I, Berger-Jones K, Buhrer C, Brandl U, Obladen M. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr.\u20081999;88:661\u2013663","DOI":"10.1111\/j.1651-2227.1999.tb00018.x"},{"key":"2021121006502503900_R141","doi-asserted-by":"crossref","unstructured":"Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatrics.\u20081991;88:828\u2013833","DOI":"10.1542\/peds.88.4.828"},{"key":"2021121006502503900_R142","doi-asserted-by":"crossref","unstructured":"Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the collaborative perinatal project. Pediatrics.\u20081993;92:651\u2013657","DOI":"10.1542\/peds.92.5.651"},{"key":"2021121006502503900_R143","unstructured":"Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics.\u20081990;85:455\u2013463"},{"key":"2021121006502503900_R144","doi-asserted-by":"crossref","unstructured":"Scheidt PC, Graubard BI, Nelson KB, et al. Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics.\u20081991;87:797\u2013805","DOI":"10.1542\/peds.87.6.797"},{"key":"2021121006502503900_R145","unstructured":"Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R. Effect of phototherapy for neonatal jaundice on cognitive performance. J Perinatol.\u20081994;14:23\u201328"},{"key":"2021121006502503900_R146","unstructured":"Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics.\u20081985;75:417\u2013421"},{"key":"2021121006502503900_R147","doi-asserted-by":"crossref","unstructured":"Hovi L, Siimes MA. Exchange transfusion with fresh heparinized blood is a safe procedure: Experiences from 1069 newborns. Acta Paediatr Scand.\u20081985;74:360\u2013365","DOI":"10.1111\/j.1651-2227.1985.tb10984.x"},{"key":"2021121006502503900_R148","doi-asserted-by":"crossref","unstructured":"Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics.\u20081997;99(5):e7. Available at: www.pediatrics.org\/cgi\/content\/full\/99\/5\/e7","DOI":"10.1542\/peds.99.5.e7"},{"key":"2021121006502503900_R149","doi-asserted-by":"crossref","unstructured":"Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med.\u20081996;334:1685\u20131690","DOI":"10.1056\/NEJM199606273342601"},{"key":"2021121006502503900_R150","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics.\u20081995;96:730\u2013733","DOI":"10.1542\/peds.96.4.730"},{"key":"2021121006502503900_R151","doi-asserted-by":"crossref","unstructured":"Bratlid D. How bilirubin gets into the brain. Clin Perinatol.\u20081990;17:449\u2013465","DOI":"10.1016\/S0095-5108(18)30578-5"},{"key":"2021121006502503900_R152","doi-asserted-by":"crossref","unstructured":"Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics.\u20081982;69:481\u2013485","DOI":"10.1542\/peds.69.4.481"},{"key":"2021121006502503900_R153","doi-asserted-by":"crossref","unstructured":"Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn.\u20081992;34:642\u2013647","DOI":"10.1111\/j.1442-200X.1992.tb01024.x"},{"key":"2021121006502503900_R154","doi-asserted-by":"crossref","unstructured":"Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics.\u20081994;93:50\u201353","DOI":"10.1542\/peds.93.1.50"},{"key":"2021121006502503900_R155","doi-asserted-by":"crossref","unstructured":"Amin SB, Ahlfors CE, Orlando MS, Dalzell LE, Merle KS, Guillet R. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics.\u20082001;107:664\u2013670","DOI":"10.1542\/peds.107.4.664"},{"key":"2021121006502503900_R156","unstructured":"Johnson L, Boggs TR. Bilirubin-dependent brain damage: incidence and indications for treatment. In: Odell GB, Schaffer R, Simopoulos AP, eds. Phototherapy in the Newborn: An Overview. Washington, DC: National Academy of Sciences; 1974:122\u2013149"},{"key":"2021121006502503900_R157","doi-asserted-by":"crossref","unstructured":"Odell GB, Storey GNB, Rosenberg LA. Studies in kernicterus. 3. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr.\u20081970;76:12\u201321","DOI":"10.1016\/S0022-3476(70)80124-X"},{"key":"2021121006502503900_R158","doi-asserted-by":"crossref","unstructured":"Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics.\u20081994;93:488\u2013494","DOI":"10.1542\/peds.93.3.488"},{"key":"2021121006502503900_R159","doi-asserted-by":"crossref","unstructured":"Cashore WJ. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr.\u20081980;96:521\u2013527","DOI":"10.1016\/S0022-3476(80)80860-2"},{"key":"2021121006502503900_R160","doi-asserted-by":"crossref","unstructured":"Ebbesen F, Brodersen R. Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood\/brain bilirubin transfer equilibrium. Early Hum Dev.\u20081982;6:341\u2013355","DOI":"10.1016\/0378-3782(82)90072-X"},{"key":"2021121006502503900_R161","doi-asserted-by":"crossref","unstructured":"Cashore WJ, Oh W, Brodersen R. Reserve albumin and bilirubin toxicity index in infant serum. Acta Paediatr Scand.\u20081983;72:415\u2013419","DOI":"10.1111\/j.1651-2227.1983.tb09739.x"},{"key":"2021121006502503900_R162","doi-asserted-by":"crossref","unstructured":"Ebbesen F, Nyboe J. Postnatal changes in the ability of plasma albumin to bind bilirubin. Acta Paediatr Scand.\u20081983;72:665\u2013670","DOI":"10.1111\/j.1651-2227.1983.tb09791.x"},{"key":"2021121006502503900_R163","doi-asserted-by":"crossref","unstructured":"Esbjorner E. Albumin binding properties in relation to bilirubin and albumin concentrations during the first week of life. Acta Paediatr Scand.\u20081991;80:400\u2013405","DOI":"10.1111\/j.1651-2227.1991.tb11873.x"},{"key":"2021121006502503900_R164","unstructured":"Robertson A, Sharp C, Karp W. The relationship of gestational age to reserve albumin concentration for binding of bilirubin. J Perinatol.\u20081988;8:17\u201318"},{"key":"2021121006502503900_R165","unstructured":"Wennberg RP. Cellular basis of bilirubin toxicity. N Y State J Med.\u20081991;91:493\u2013496"},{"key":"2021121006502503900_R166","doi-asserted-by":"crossref","unstructured":"Maisels MJ. Phototherapy\u2014traditional and nontraditional. J Perinatol.\u20082001;21(suppl 1):S93\u2013S97","DOI":"10.1038\/sj.jp.7210642"},{"key":"2021121006502503900_R167","unstructured":"Fiberoptic phototherapy systems. Health Devices.\u20081995;24:132\u2013153"},{"key":"2021121006502503900_R168","unstructured":"International Electrotechnical Commission. Medical electrical equipment\u2014part 2-50: particular requirements for the safety of infant phototherapy equipment. 2000. IEC 60601-2-50. Available at www.iec.ch. Accessed June 7, 2004"},{"key":"2021121006502503900_R169","doi-asserted-by":"crossref","unstructured":"Tan KL. The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinemia. Pediatr Res.\u20081982;16:670\u2013674","DOI":"10.1203\/00006450-198208000-00018"},{"key":"2021121006502503900_R170","doi-asserted-by":"crossref","unstructured":"Maisels MJ. Why use homeopathic doses of phototherapy?Pediatrics.\u20081996;98:283\u2013287","DOI":"10.1542\/peds.98.2.283"},{"key":"2021121006502503900_R171","doi-asserted-by":"crossref","unstructured":"Seidman DS, Moise J, Ergaz Z, et al. A new blue light-emitting phototherapy device: a prospective randomized controlled study. J Pediatr.\u20082000;136:771\u2013774","DOI":"10.1016\/S0022-3476(00)75202-4"},{"key":"2021121006502503900_R172","doi-asserted-by":"crossref","unstructured":"Ennever JF. Blue light, green light, white light, more light: treatment of neonatal jaundice. Clin Perinatol.\u20081990;17:467\u2013481","DOI":"10.1016\/S0095-5108(18)30579-7"},{"key":"2021121006502503900_R173","doi-asserted-by":"crossref","unstructured":"Garg AK, Prasad RS, Hifzi IA. A controlled trial of high-intensity double-surface phototherapy on a fluid bed versus conventional phototherapy in neonatal jaundice. Pediatrics.\u20081995;95:914\u2013916","DOI":"10.1542\/peds.95.6.914"},{"key":"2021121006502503900_R174","doi-asserted-by":"crossref","unstructured":"Tan KL. Phototherapy for neonatal jaundice. Clin Perinatol.\u20081991;18:423\u2013439","DOI":"10.1016\/S0095-5108(18)30506-2"},{"key":"2021121006502503900_R175","doi-asserted-by":"crossref","unstructured":"Eggert P, Stick C, Schroder H. On the distribution of irradiation intensity in phototherapy. Measurements of effective irradiance in an incubator. Eur J Pediatr.\u20081984;142:58\u201361","DOI":"10.1007\/BF00442593"},{"key":"2021121006502503900_R176","doi-asserted-by":"crossref","unstructured":"Hansen TW. Acute management of extreme neonatal jaundice\u2014the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr.\u20081997;86:843\u2013846","DOI":"10.1111\/j.1651-2227.1997.tb08608.x"},{"key":"2021121006502503900_R177","doi-asserted-by":"crossref","unstructured":"Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg\/dL or more in a large managed care organization. Pediatrics.\u20082003;111(6 Pt 1):1303\u20131311","DOI":"10.1542\/peds.111.6.1303"},{"key":"2021121006502503900_R178","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Kring E. Bilirubin rebound following intensive phototherapy. Arch Pediatr Adolesc Med.\u20082002;156:669\u2013672","DOI":"10.1001\/archpedi.156.7.669"},{"key":"2021121006502503900_R179","doi-asserted-by":"crossref","unstructured":"Tan KL. Comparison of the efficacy of fiberoptic and conventional phototherapy for neonatal hyperbilirubinemia. J Pediatr.\u20081994;125:607\u2013612","DOI":"10.1016\/S0022-3476(94)70019-2"},{"key":"2021121006502503900_R180","doi-asserted-by":"crossref","unstructured":"Rubaltelli FF, Zanardo V, Granati B. Effect of various phototherapy regimens on bilirubin decrement. Pediatrics.\u20081978;61:838\u2013841","DOI":"10.1542\/peds.61.6.838"},{"key":"2021121006502503900_R181","doi-asserted-by":"crossref","unstructured":"Maurer HM, Shumway CN, Draper DA, Hossaini AA. Controlled trial comparing agar, intermittent phototherapy, and continuous phototherapy for reducing neonatal hyperbilirubinemia. J Pediatr.\u20081973;82:73\u201376","DOI":"10.1016\/S0022-3476(73)80014-9"},{"key":"2021121006502503900_R182","doi-asserted-by":"crossref","unstructured":"Lau SP, Fung KP. Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice. Arch Dis Child.\u20081984;59:892\u2013894","DOI":"10.1136\/adc.59.9.892"},{"key":"2021121006502503900_R183","doi-asserted-by":"crossref","unstructured":"McDonagh AF, Lightner DA. \u2018Like a shrivelled blood orange\u2019\u2014bilirubin, jaundice, and phototherapy. Pediatrics.\u20081985;75:443\u2013455","DOI":"10.1542\/peds.75.3.443"},{"key":"2021121006502503900_R184","doi-asserted-by":"crossref","unstructured":"Yetman RJ, Parks DK, Huseby V, Mistry K, Garcia J. Rebound bilirubin levels in infants receiving phototherapy. J Pediatr.\u20081998;133:705\u2013707","DOI":"10.1016\/S0022-3476(98)70117-9"},{"key":"2021121006502503900_R185","doi-asserted-by":"crossref","unstructured":"Lazar L, Litwin A, Merlob P. Phototherapy for neonatal nonhemolytic hyperbilirubinemia. Analysis of rebound and indications for discontinuing therapy. Clin Pediatr (Phila).\u20081993;32:264\u2013267","DOI":"10.1177\/000992289303200502"},{"key":"2021121006502503900_R186","doi-asserted-by":"crossref","unstructured":"Cremer RJ, Perryman PW, Richards DH. Influence of light on the hyperbilirubinemia of infants. Lancet.\u20081958;1(7030):1094\u20131097","DOI":"10.1016\/S0140-6736(58)91849-X"},{"key":"2021121006502503900_R187","doi-asserted-by":"crossref","unstructured":"Rubaltelli FF, Jori G, Reddi E. Bronze baby syndrome: a new porphyrin-related disorder. Pediatr Res.\u20081983;17:327\u2013330","DOI":"10.1203\/00006450-198305000-00004"},{"key":"2021121006502503900_R188","doi-asserted-by":"crossref","unstructured":"Meisel P, Jahrig D, Theel L, Ordt A, Jahrig K. The bronze baby syndrome: consequence of impaired excretion of photobilirubin?Photobiochem Photobiophys.\u20081982;3:345\u2013352","DOI":"10.1016\/S0165-8646(24)00461-6"},{"key":"2021121006502503900_R189","doi-asserted-by":"crossref","unstructured":"Mallon E, Wojnarowska F, Hope P, Elder G. Neonatal bullous eruption as a result of transient porphyrinemia in a premature infant with hemolytic disease of the newborn. J Am Acad Dermatol.\u20081995;33:333\u2013336","DOI":"10.1016\/0190-9622(95)91428-5"},{"key":"2021121006502503900_R190","doi-asserted-by":"crossref","unstructured":"Paller AS, Eramo LR, Farrell EE, Millard DD, Honig PJ, Cunningham BB. Purpuric phototherapy-induced eruption in transfused neonates: relation to transient porphyrinemia. Pediatrics.\u20081997;100:360\u2013364","DOI":"10.1542\/peds.100.3.360"},{"key":"2021121006502503900_R191","unstructured":"Tonz O, Vogt J, Filippini L, Simmler F, Wachsmuth ED, Winterhalter KH. Severe light dermatosis following phototherapy in a newborn infant with congenital erythropoietic urophyria [in German]. Helv Paediatr Acta.\u20081975;30:47\u201356"},{"key":"2021121006502503900_R192","doi-asserted-by":"crossref","unstructured":"Soylu A, Kavukcu S, Turkmen M. Phototherapy sequela in a child with congenital erythropoietic porphyria. Eur J Pediatr.\u20081999;158:526\u2013527","DOI":"10.1007\/s004310051136"},{"key":"2021121006502503900_R193","doi-asserted-by":"crossref","unstructured":"Kearns GL, Williams BJ, Timmons OD. Fluorescein phototoxicity in a premature infant. J Pediatr.\u20081985;107:796\u2013798","DOI":"10.1016\/S0022-3476(85)80421-2"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/1\/297\/1005960\/zpe00704000297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/114\/1\/297\/1005960\/zpe00704000297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T07:51:38Z","timestamp":1734508298000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/114\/1\/297\/64771\/Management-of-Hyperbilirubinemia-in-the-Newborn"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":193,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,7,1]]},"published-print":{"date-parts":[[2004,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.114.1.297","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,1]]}}}